THURMAN RANDY H Insider Trading Activity (OTLK)

Summary

Updated Jul 16, 2026

THURMAN RANDY H has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $2K.

Profile

Role	Director
Notability	20/100

Board memberships

Outlook Therapeutics, Inc.

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-05-27	OTLK	Outlook Therapeutics, Inc.	P — Open-market purchase	5.0K	$0.43	$2K

Companies — Last 90 Days

Outlook Therapeutics, Inc. (OTLK) — 1 filings, last 2026-05-27

Frequently Asked Questions

Who is THURMAN RANDY H?

THURMAN RANDY H is a corporate insider — currently tracked as Director of Outlook Therapeutics, Inc. (OTLK). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has THURMAN RANDY H submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has THURMAN RANDY H been buying or selling stock?

Recorded transactions: 1 open-market purchases ($2K) and 0 open-market sales () across all tracked filings.

Where can I see all of THURMAN RANDY H's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

THURMAN RANDY H — SEC Form 4 Insider Trading Activity